Floatz logo

Ropinirole

Restless Leg Syndrome

Roxane LaboratoriesSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Restless Leg Syndrome cohort.

Asset / SponsorPhaseRating
Ropinirole
GlaxoSmithKline
Phase 4A
FERRIC CATION
University of Zurich
Phase 4BBB
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Mayo Clinic
Phase 4BB
VITAMIN D
University of Sao Paulo General Hospital
Phase 4BB
Ctc-501
Massachusetts General Hospital
Phase 4BB

View all 9 →

Same molecule, other indications

Ropinirole is also rated in:

restless legs syndromeDormant
A
Indicative ·
81 / 100
View asset →
Parkinson diseaseDormant
BBB
Indicative ·
76 / 100
View asset →
Parkinson diseaseDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →